Adjunctive treatment and BoNT-A for post-stroke spasticity: Are we really focusing on the patient-centered goals?
作者信息
Baricich Alessio, Bertoni Michele, Santamato Andrea, Osio Maurizio, Gasperini Giulio, Picelli Alessandro, Molteni Franco
机构信息
Department of Health Sciences, Università del Piemonte Orientale, Physical Medicine and Rehabilitation, Maggiore della Carità University Hospital, Novara, Italy.
Physical Medicine and Rehabilitation, ASST Settelaghi, Varese, Italy.
出版信息
Front Neurol. 2023 Mar 10;14:1134691. doi: 10.3389/fneur.2023.1134691. eCollection 2023.
Abstract
摘要
相似文献
1
Adjunctive treatment and BoNT-A for post-stroke spasticity: Are we really focusing on the patient-centered goals?辅助治疗与肉毒杆菌毒素A治疗中风后痉挛：我们真的在关注以患者为中心的目标吗？
Front Neurol. 2023 Mar 10;14:1134691. doi: 10.3389/fneur.2023.1134691. eCollection 2023.
2
The Effectiveness of Botulinum Toxin Type A (BoNT-A) Treatment in Brazilian Patients with Chronic Post-Stroke Spasticity: Results from the Observational, Multicenter, Prospective BCause Study.A型肉毒毒素（BoNT-A）治疗巴西慢性卒中后痉挛患者的疗效：来自观察性、多中心、前瞻性 BCause 研究的结果。
Toxins (Basel). 2020 Dec 4;12(12):770. doi: 10.3390/toxins12120770.
3
Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity.肉毒杆菌毒素及其他局部肌肉注射治疗中风后痉挛后的多学科康复治疗
Cochrane Database Syst Rev. 2013 Jun 5;2013(6):CD009689. doi: 10.1002/14651858.CD009689.pub2.
4
BoNT-A for Post-Stroke Spasticity: Guidance on Unmet Clinical Needs from a Delphi Panel Approach.肉毒毒素 A 治疗脑卒中后痉挛：德尔菲法小组探讨未满足的临床需求。
Toxins (Basel). 2021 Mar 25;13(4):236. doi: 10.3390/toxins13040236.
5
The Use of Botulinum Toxin for Treatment of Spasticity.肉毒杆菌毒素在痉挛治疗中的应用。
Handb Exp Pharmacol. 2021;263:127-146. doi: 10.1007/164_2019_315.
6
[Treatment goals in patients with post-stroke upper limb spasticity following injection of botulinum toxin A : Results of the German-Austrian subgroup of the ULIS-II study].[注射A型肉毒杆菌毒素后中风后上肢痉挛患者的治疗目标：ULIS-II研究的德奥亚组结果]
Nervenarzt. 2019 Apr;90(4):361-370. doi: 10.1007/s00115-018-0630-1.
7
Botulinum Toxin Type A Improves Function According to Goal Attainment in Adults with Poststroke Lower Limb Spasticity in Real Life Practice.A型肉毒毒素在真实生活实践中改善了成人卒中后下肢痉挛患者的功能，依据目标实现情况而定。
Eur Neurol. 2019;82(1-3):1-8. doi: 10.1159/000503172. Epub 2019 Nov 14.
8
Assessment, goal setting, and botulinum neurotoxin a therapy in the management of post-stroke spastic movement disorder: updated perspectives on best practice.评估、目标设定及肉毒杆菌神经毒素A疗法在中风后痉挛性运动障碍管理中的应用：最佳实践的最新观点
Expert Rev Neurother. 2022 Jan;22(1):27-42. doi: 10.1080/14737175.2021.2021072. Epub 2021 Dec 30.
9
Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke.A型肉毒毒素治疗脑卒中后下肢痉挛。
Drugs. 2019 Feb;79(2):143-160. doi: 10.1007/s40265-018-1042-z.
10
Cortical activation changes in patients suffering from post-stroke arm spasticity and treated with botulinum toxin a.中风后手臂痉挛患者接受A型肉毒杆菌毒素治疗后的皮质激活变化
J Neuroimaging. 2013 Jul;23(3):337-44. doi: 10.1111/j.1552-6569.2011.00682.x. Epub 2011 Dec 30.
引用本文的文献
1
Post-stroke spasticity: follow-up and functional implications of chronic long-term treatment with botulinum toxin.脑卒中后痉挛：肉毒毒素慢性长期治疗的随访结果及其对功能的影响。
Eur J Phys Rehabil Med. 2024 Aug;60(4):581-590. doi: 10.23736/S1973-9087.24.08429-6. Epub 2024 Jun 18.
2
Transient Worsening of Dysphagia and Dysarthria after Treatment with Botulinum Toxin in Patients with Acquired Brain Injury.获得性脑损伤患者接受肉毒杆菌毒素治疗后吞咽困难和构音障碍的短暂加重
Healthcare (Basel). 2023 Dec 7;11(24):3117. doi: 10.3390/healthcare11243117.
3
Botulinum toxin use in patients with post-stroke spasticity: a nationwide retrospective study from France.肉毒杆菌毒素用于中风后痉挛患者：一项来自法国的全国性回顾性研究。
Front Neurol. 2023 Aug 23;14:1245228. doi: 10.3389/fneur.2023.1245228. eCollection 2023.
本文引用的文献
1
BoNT-A for Post-Stroke Spasticity: Guidance on Unmet Clinical Needs from a Delphi Panel Approach.肉毒毒素 A 治疗脑卒中后痉挛：德尔菲法小组探讨未满足的临床需求。
Toxins (Basel). 2021 Mar 25;13(4):236. doi: 10.3390/toxins13040236.
2
Long-term adherence and response to botulinum toxin in different indications.不同适应证下肉毒毒素的长期依从性和应答反应。
Ann Clin Transl Neurol. 2021 Jan;8(1):15-28. doi: 10.1002/acn3.51225. Epub 2020 Dec 1.
3
Efficacy of botulinum toxin A for the treatment of hemiparesis in adults with chronic upper limb spasticity.A型肉毒杆菌毒素治疗成人慢性上肢痉挛性偏瘫的疗效
Pan Afr Med J. 2020 Feb 25;35:55. doi: 10.11604/pamj.2020.35.55.16091. eCollection 2020.
4
Botulinum Toxin Therapy Combined with Rehabilitation for Stroke: A Systematic Review of Effect on Motor Function.肉毒毒素治疗联合康复治疗脑卒中：对运动功能影响的系统评价。
Toxins (Basel). 2019 Dec 5;11(12):707. doi: 10.3390/toxins11120707.
5
Botulinum Toxin Type A Improves Function According to Goal Attainment in Adults with Poststroke Lower Limb Spasticity in Real Life Practice.A型肉毒毒素在真实生活实践中改善了成人卒中后下肢痉挛患者的功能，依据目标实现情况而定。
Eur Neurol. 2019;82(1-3):1-8. doi: 10.1159/000503172. Epub 2019 Nov 14.
6
Efficacy and Safety of Botulinum Toxin Type A for Limb Spasticity after Stroke: A Meta-Analysis of Randomized Controlled Trials.A型肉毒毒素治疗脑卒中后肢体痉挛的疗效和安全性：一项随机对照试验的荟萃分析。
Biomed Res Int. 2019 Apr 7;2019:8329306. doi: 10.1155/2019/8329306. eCollection 2019.
7
Effectiveness of Botulinum Toxin Treatment for Upper Limb Spasticity Poststroke Over Different ICF Domains: A Systematic Review and Meta-Analysis.脑卒后患上肢痉挛的肉毒毒素治疗效果：基于 ICF 不同领域的系统评价和荟萃分析。
Arch Phys Med Rehabil. 2019 Sep;100(9):1703-1725. doi: 10.1016/j.apmr.2019.01.016. Epub 2019 Feb 21.
8
Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke.A型肉毒毒素治疗脑卒中后下肢痉挛。
Drugs. 2019 Feb;79(2):143-160. doi: 10.1007/s40265-018-1042-z.
9
Adjuvant treatments associated with botulinum toxin injection for managing spasticity: An overview of the literature.辅助治疗与肉毒毒素注射治疗痉挛：文献综述。
Ann Phys Rehabil Med. 2019 Jul;62(4):291-296. doi: 10.1016/j.rehab.2018.08.004. Epub 2018 Sep 13.
10
Therapy influences goal attainment following botulinum neurotoxin injection for focal spasticity in adults with neurological conditions.对于患有神经系统疾病的成人，肉毒杆菌神经毒素注射治疗局灶性痉挛后，治疗会影响目标达成情况。
Brain Inj. 2018;32(7):948-956. doi: 10.1080/02699052.2018.1469044. Epub 2018 May 2.
Zotero 插件